UTRADE brought to you by UOB Kay Hian

Would you be interested in the Business Strategies, Competitive Strengths and Key Risks?

Log in or Become a UTRADE Client Now

Latest IPO

Competitive Margin Interest Rates $0 Handling Fee on Cash Applications for New Self-Serviced Clients # Login to Subscribe
Planned Offering Offering Closing Date Settlement Refund / Grey Market Trading
2022

JAN

FEB
2021222324252627282930310102030405060708
IPO Calendar
Planned IPOs
Stock Offer Period Trading Price（HKD） BoardLot IndicativeInterest Rate UOBKH'sClosing Date Sponsor(s) Oversubscription
IPO Calendar
 2121AINNOVATION 17/01/202220/01/2022 27/01/2022 26.3027.30 100 1.68% 19/01/2022

UBS

CICC

China Renaissance

Day 1：<1.44x

Day 2：<3.70x

Day 3：<6.1x
Planned IPOs *
[Planned]
Huitongda Passed PHIP on 9 Jan N/A N/A N/A N/A N/A

CICC*

Citi*

China Renaissance*

 -
[Planned]
Everjoy Services Passed PHIP 23 Dec N/A N/A N/A N/A N/A

HUATAI*

 -
[Planned]
Bioer Technology Passed PHIP on 19 Dec N/A N/A N/A N/A N/A

CICC*

 -
[Planned]
China Tourism Group Passed PHIP on 22 Nov N/A N/A N/A N/A N/A

CICC*

UBS*

 -
[Planned]
Shinsun Lifestyle Passed PHIP on 22 Nov N/A N/A N/A N/A N/A

ABCI*

CCBI*

 -
[Planned]
Horizon Construction Passed PHIP on 15 Nov N/A N/A N/A N/A N/A

Huatai*

Citi*

CMBI*

DBS*

 -
[Planned]
WEILONG Delicious Passed PHIP on 14 Nov 2022* N/A N/A N/A N/A

Morgan Stanley*

CICC*

UBS*

 -
[Planned]
ZOINA Service Passed PHIP on 12 Nov N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
TI Cloud Passed PHIP on 15 Dec N/A N/A N/A N/A N/A

CICC*

 -
[Planned]
IQIYI N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
FUTU N/A N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

 -
[Planned]
Ximalaya N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Novotech Health Passed PHIP on 5 Sep N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

 -
[Planned]
AInnovation Application Submitted* N/A N/A N/A N/A N/A

UBS*

CICC*

China Renaissance*

 -
[Planned]
Imeik Technology Dev N/A N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

 -
[Planned]
Edding Group Passed PHIP on 25 Jun N/A N/A N/A N/A N/A

Morgan Stanley*

Credit Suisse*

 -
[Planned]
eBeauty Passed PHIP on 23 Jun N/A N/A N/A N/A N/A

CITIC*

Credit Suisse*

 -
[Planned]
Chief Group Application Submitted* N/A N/A N/A N/A N/A

BOCOM*

 -
[Planned]
Konew Financial N/A N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
LexinFintech N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Top Glove N/A 2022 Q1* N/A N/A N/A N/A

CICC*

 -
[Planned]
Fangzhi Group Application Submitted* N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
Wanda Group N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
DRC Bank N/A N/A N/A N/A N/A N/A

CMS*

CMBI*

ABCI*

ICBC*

 -
[Planned]
Hanyu Medical Passed PHIP on 13 Sep N/A N/A N/A N/A N/A

CITIC*

Citi*

 -
[Planned]
XiaoDian N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Medbanks N/A N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

Haitong*

 -
[Planned]
NIO N/A N/A N/A N/A N/A N/A

Credit Suisse*

Morgan Stanley*

 -
[Planned]
YiSheng Biopharma Application Submitted* N/A N/A N/A N/A N/A

Morgan Stanley*

Haitong*

 -
[Planned]
Novotech N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
ECARX N/A N/A N/A N/A N/A N/A

Morgan Stanley*

UBS*

 -
[Planned]
Betta Pharmaceuticals Passed PHIP on 30 May N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

CITIC*

 -
[Planned]
Recbio N/A 2022* N/A N/A N/A N/A

Morgan Stanley*

CMBI*

CITIC*

 -
[Planned]
DIDA CHUXING Application Submitted* N/A N/A N/A N/A N/A

Haitong*

Nomura*

 -
[Planned]
DiDi N/A 2022* N/A N/A N/A N/A

Goldman Sachs*

 -

# Terms and Conditions Apply

*Market News

：UOB Kay Hian (UOBKH) is one of the participants

Copyright ©, UOB Kay Hian (Hong Kong) Ltd. All rights reserved. Securities & Futures Commission Registered: CE Number AAW261 Client Agreement-Terms & Conditions ( Securities / Futures )